Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
Your new goal for communications – social impact
The future of healthcare professional engagement14 Jun 2022
By Ilana Scholl
Using consensus to drive clarity08 Apr 2022
By Derek Annan
Discovering the unique power of DOLs – are you harnessing the power of pharma’s new educators?10 Jan 2022
By Akarsh Sakalaspur
What if pharma engaged its customers like Netflix or Amazon?06 Jan 2022
By Lorraine Walters
Omnichannel marketing – more than a buzzword06 Jan 2022
By Dimitri Challouma and Dominic Cleall
Not another thought leadership article… sorting the wheat from the chaff11 Nov 2021
By Rob Barlow
Making social sexy15 Apr 2021
By Amy Johnson
Novartis and smartpatient launch app experience for wet AMD patients19 Nov 2020
Wet AMD is the leading cause of severe vision loss and legal blindness in people over the age of 65
Innovation in the time of coronavirus14 Apr 2020
The Distancer is a simple, handheld device that aims to help ensure the safety of key workers
Share
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- bluebird bio reveals plans to launch two gene therapies
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- The patient voice – the value of patient-reported outcomes in HTA
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- My body. My choice. Are we all talking about the same thing?
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Sanofi halts recruitment for trials assessing MS treatment
- Merck and Cerevance to research novel targets in Alzheimer’s disease
- Michael J Fox Foundation awards Koneksa second research grant
- FDA approves Bot Image’s AI software for the detection and diagnosis of prostate cancer
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- Avastin wins EU approval for advanced renal cancer
- GSK/Merck KGgA cancer drug fails in third trial
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- Roche shares new positive Ocrevus data for MS patients
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
